Jump Financial’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
Jump Financial's GLUE Position: Q3 2026 in Review
Jump Financial increased its Monte Rosa Therapeutics (GLUE) stake by 309% in Q3 2026, buying an estimated $1.85M and bringing the position to 142,681 shares worth $1.7M. The position accounts for 0.01% of the portfolio, ranked #1109.
Jump Financial first reported a position in GLUE in Q3 2022 and has held it in 7 quarters since. The position peaked at $3.04M in Q1 2026. 148 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- Jump Financial held 142,681 shares of Monte Rosa Therapeutics worth $1.7M as of Q3 2026.
- Jump Financial bought 107,781 Monte Rosa Therapeutics shares in Q3 2026, an estimated $1.85M.
- Monte Rosa Therapeutics made up 0.01% of Jump Financial's portfolio in Q3 2026, its #1109 holding.
- Jump Financial first reported a position in Monte Rosa Therapeutics in Q3 2022 and has held it in 7 quarters since.
- Jump Financial's Monte Rosa Therapeutics position peaked at $3.04M in Q1 2026.
- 148 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.